72 related articles for article (PubMed ID: 7768142)
1. [Effects of methylprednisolone pulse therapy on TNF alpha levels in chronic nephritis].
Bai LQ; Chen XM; Mao J
Zhonghua Nei Ke Za Zhi; 1994 Dec; 33(12):827-9. PubMed ID: 7768142
[TBL] [Abstract][Full Text] [Related]
2. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
Bahat E; Akkaya BK; Akman S; Karpuzoglu G; Guven AG
J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629
[TBL] [Abstract][Full Text] [Related]
3. Glomerular ICAM-1 expression related to circulating TNF-alpha in human glomerulonephritis.
Yokoyama H; Takaeda M; Wada T; Ohta S; Hisada Y; Segawa C; Furuichi K; Kobayashi K
Nephron; 1997; 76(4):425-33. PubMed ID: 9274840
[TBL] [Abstract][Full Text] [Related]
4. [Effect of methylprednisolone pulse therapy in patients with lupus nephritis assessed by WHO morphologic classification].
Makino H; Yamasaki Y; Hayashi Y; Haramoto T; Shikata K; Kumagai I; Taniai K; Takahashi K; Ota Z
Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):791-9. PubMed ID: 2273595
[TBL] [Abstract][Full Text] [Related]
5. Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis.
Tang Z; Zhou H; Yao X; Hu W; Leishi L
Chin Med J (Engl); 1997 Mar; 110(3):206-9. PubMed ID: 9594342
[TBL] [Abstract][Full Text] [Related]
6. [Double blind trial of pulse methylprednisolone versus conventional oral prednisolone in lupus nephritis].
Honma M; Ichikawa Y; Akizuki M; Kashiwazaki S; Kondo H; Hashimoto H; Sugawara M; Hanaoka K
Ryumachi; 1994 Jun; 34(3):616-27. PubMed ID: 8052927
[TBL] [Abstract][Full Text] [Related]
7. Effect of prophylactic intracerebroventricular injection of methylprednisolone on nitrogen and catecholamine excretion in the urine after laparotomy in rats.
Tajiri T; Yoshida S; Ishibashi N; Tanaka K; Muraoka T; Shirouzu K
J Surg Res; 2002 Apr; 103(2):272-8. PubMed ID: 11922745
[TBL] [Abstract][Full Text] [Related]
8. Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy.
Bergstein JM; Andreoli SP
Pediatr Nephrol; 1995 Jun; 9(3):268-71. PubMed ID: 7632508
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
Arends S; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M; Berden JH;
Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
[TBL] [Abstract][Full Text] [Related]
10. Modulation of glomerular structure and function in murine lupus nephritis by methylprednisolone and cyclophosphamide.
Kiberd BA; Young ID
J Lab Clin Med; 1994 Oct; 124(4):496-506. PubMed ID: 7930875
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of rapid progressive glomerulonephritis (RPGN) with pulse methylprednisolone (MP) and urokinase (UK): a renal rebiopsy study].
Chen XM; Cheng QL
Zhonghua Nei Ke Za Zhi; 1993 Sep; 32(9):607-9. PubMed ID: 8112145
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors of clinical outcome in patients with diffuse proliferative lupus nephritis treated early by intravenous methylprednisolone pulse therapy.
Kanno A; Hotta O; Yusa N; Taguma Y
Ren Fail; 2007; 29(1):41-7. PubMed ID: 17365909
[TBL] [Abstract][Full Text] [Related]
13. [Effects of methylprednisolone pulse therapy in the insidious type of crescentic glomerulonephritis].
Takeda S; Kida H; Takazakura E; Yokoyama H; Kobayashi K
Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):490-6. PubMed ID: 9379560
[TBL] [Abstract][Full Text] [Related]
14. Methylprednisolone in systemic lupus erythematosus.
Howe HS; Boey ML; Feng PH
Singapore Med J; 1990 Feb; 31(1):18-21. PubMed ID: 2333537
[TBL] [Abstract][Full Text] [Related]
15. [Methylprednisolone pulse therapy in the early phases of lupus nephritis].
Mitić I; Fele D; Lenert P; Curić S; Vodopivec S; Bozić D; Sakac V; Djisalov M; Ilić T; Sebić L; Djurdjević-Mirković T; Tepavcević P
Srp Arh Celok Lek; 1996; 124 Suppl 1():67-9. PubMed ID: 9102936
[TBL] [Abstract][Full Text] [Related]
16. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.
Yee CS; Gordon C; Dostal C; Petera P; Dadoniene J; Griffiths B; Rozman B; Isenberg DA; Sturfelt G; Nived O; Turney JH; Venalis A; Adu D; Smolen JS; Emery P
Ann Rheum Dis; 2004 May; 63(5):525-9. PubMed ID: 15082482
[TBL] [Abstract][Full Text] [Related]
17. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
Tang Z; Zhang J; Zhang S; Li L
Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
[TBL] [Abstract][Full Text] [Related]
18. Up-regulated renal expression of TNF-alpha signalling adapter proteins in lupus glomerulonephritis.
Zhu L; Yang X; Ji Y; Chen W; Guan W; Zhou SF; Yu X
Lupus; 2009 Feb; 18(2):116-27. PubMed ID: 19151112
[TBL] [Abstract][Full Text] [Related]
19. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
20. Pulse methylprednisolone therapy in children with membranoproliferative glomerulonephritis.
Emre S; Sirin A; Alpay H; Tanman F; Uysal V; Nayir A; Bilge I
Acta Paediatr Jpn; 1995 Oct; 37(5):626-9. PubMed ID: 8533592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
